Impact of Neutrophil Lymphocyte and Monocyte Lymphocyte Ratio on Chronic Kidney Disease Patients Outcome

NCT05887960 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-06-05

No results posted yet for this study

Summary

The aim of this study is to establish NLR, MLR as a good predictors for outcome of CKD including hemodialysis and CKD stage (4-5) patients as regard inflammation, malnutrition and anemia on cardiovascular complication.

Conditions

  • Hemodialysis Complication

Interventions

OTHER

CBC and flow cytometry test for monocyte

all groups assigned Cbc with leukocyte differential and flow cytometry for monocyte population

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ashraf AN el shazly, profeassor · Assiut University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-07-31
Completion
2024-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05887960 on ClinicalTrials.gov